Hard exudates in diabetic macular edema after intravitreal anti-VEGF therapy: a post-hoc analysis of the DRCR protocol T trial
Following anti-VEGF for DME, HEs initially increase, followed by a subsequent decrease over one year. Greater extent of HEs at baseline is associated with worse visual outcomes at one year.
Authors
- Srinivas R. Sadda (ORCID: https://orcid.org/0000-0002-4939-3306)
- Chang-Ki Yoon
- Kangyeun Pak
Institutions
- University of California, Los Angeles (US)
- Seoul National University Hospital (KR)
- Doheny Eye Institute (US)
- Inje University Haeundae Paik Hospital (KR)
Publication Details
- Journal
- Graefe s Archive for Clinical and Experimental Ophthalmology
- Published
- 2025-11-08
- DOI
- https://doi.org/10.1007/s00417-025-07015-0
- Citations
- 1
- Primary Topic
- Retinal Diseases and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 1.71
Funders
- National Institutes of Health